» Authors » Zhiwan Zheng

Zhiwan Zheng

Explore the profile of Zhiwan Zheng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 69
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou Q, Zheng Z, Yin S, Duan D, Liao X, Xiao Y, et al.
Parasit Vectors . 2024 Jul; 17(1):288. PMID: 38971783
Background: Currently, treatment regimens for visceral leishmaniasis (VL) are limited because of the presence of numerous adverse effects. Nicotinamide, a readily available and cost-effective vitamin, has been widely acknowledged for...
2.
Yang Y, Chen Y, Zheng Z, Lin L, Chen X, Yang C, et al.
Parasit Vectors . 2024 Jun; 17(1):256. PMID: 38867315
Background: Human toxocariasis is a neglected parasitic disease characterised by the syndromes visceral, cerebral, and ocular larva migrans. This disease is caused by the migrating larvae of Toxocara roundworms from...
3.
Yin S, Li J, Chen J, Zhou Q, Duan D, Lai M, et al.
Acta Trop . 2024 Jan; 251:107114. PMID: 38190929
Background: Visceral leishmaniasis is a neglected tropical disease affecting millions of people worldwide. Macrophages serve as the primary host cells for L. donovani, the immune response capability of these host...
4.
He J, Zhang J, Liao X, Xiao Y, Li J, Zheng Z, et al.
Parasit Vectors . 2024 Jan; 17(1):8. PMID: 38185681
Background: Leishmaniasis is mainly prevalent in tropical and subtropical developing countries, where chronic undernutrition often co-exists. Undernutrition is reported to promote the progression of leishmaniasis, but its immune mechanisms have...
5.
Liao X, He J, Wang R, Zhang J, Wei S, Xiao Y, et al.
Immunobiology . 2023 Aug; 228(5):152725. PMID: 37562277
Most of the existing Leishmania-related research about TLR-2 agonists was focusing on their role as adjuvants in the vaccine, few studied its therapeutic effect. This paper aims to explore the...
6.
Zhang J, Li J, Hu K, Zhou Q, Chen X, He J, et al.
Front Immunol . 2022 Jul; 13:902066. PMID: 35812381
Visceral leishmaniasis (VL), also known as kala-azar, is the most dangerous form of leishmaniasis. Currently no effective vaccine is available for clinical use. Since the pathogenicity of different strains is...
7.
Zheng Z, He J, Luo T, Zhang J, Zhou Q, Yin S, et al.
Animals (Basel) . 2022 Feb; 12(3). PMID: 35158645
Leishmaniasis is a neglected tropical disease threatening millions of people worldwide. The emergence of antimony-resistant strains have brought difficulties to the treatment and elimination of leishmaniasis. This study performed genome...
8.
Zhang J, He J, Liao X, Xiao Y, Liang C, Zhou Q, et al.
Immunobiology . 2021 Apr; 226(3):152085. PMID: 33910113
The most dangerous form of leishmaniasis is Visceral leishmaniasis (VL). The elimination of VL depends not only on agent treatments but also on effective vaccines against Leishmania parasites. Epitope-based vaccines...
9.
Zhou Q, Li J, Guo X, Liu J, Song Q, Gong X, et al.
Parasit Vectors . 2021 Mar; 14(1):135. PMID: 33663591
Background: Ticks are ectoparasites that feed on blood of a broad taxonomical range of terrestrial and flying vertebrates and are distributed across a wide range of environmental settings. To date,...
10.
He J, Huang F, Zhang J, Chen Q, Zheng Z, Zhou Q, et al.
J Med Virol . 2020 Oct; 93(4):2115-2131. PMID: 33091154
The global outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) urgently requires an effective vaccine for prevention. In this study, 66 epitopes containing pentapeptides of SARS-CoV-2 spike protein in...